- Financing will be used to further develop APIM Therapeutics lead anti-cancer compound towards late preclinical development. APIM Therapeutics, a preclinical biotech company focusing on the ...
Nordic Nanovector's plan to emerge from its current troubles by merging with APIM Therapeutics has hit an insurmountable hurdle – in the shape of its own shareholders. Five months after giving up on ...
Nordic Nanovector's plan to emerge from its current troubles by merging with APIM Therapeutics has hit an insurmountable hurdle – in the shape of its own shareholders. The troubled Norwegian biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback